A fast moving megatrial for coronavirus treatments, and transferring the benefits of exercise by transferring blood

Science Magazine Podcast

Science Podcast

News, News Commentary, Science

4.3 • 842 Ratings

🗓️ 9 July 2020

⏱️ 28 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Contributing correspondent Kai Kupferschmidt talks with host Sarah Crespi about the success of a fast moving megatrial for coronavirus treatments. The UK’s RECOVERY (Randomized Evaluation of COVID-19 Therapy) trial has enrolled more than 12,000 hospitalized coronavirus patients since early March and has released important recommendations that were quickly taken up by doctors and scientists around the world. Kai discusses why such a large study is necessary and why other large drug trials like the WHO’s SOLIDARITY trial are lagging behind. Also this week, producer Meagan Cantwell talks with Saul Villeda, a professor in the Department of Anatomy at University of California, San Francisco, about transferring the beneficial effects of exercise on the brain from an active mouse to a sedentary mouse by transferring their blood. This week’s episode was produced with help from Podigy. Listen to previous podcasts About the Science Podcast Download a transcript (PDF) [Image: eyesplash/Flickr; Music: Jeffrey Cook] Authors: Sarah Crespi; Meagan Cantwell; Kai Kupferschmidt Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0	This podcast is supported by the Icon School of Medicine at Mount Sinai, one of America's leading research medical schools.
0:07.8	Icon Mount Sinai is the academic arm of the eight hospital Mount Sinai health system in New York City.
0:13.9	It's consistently among the top recipients of NIH funding.
0:18.0	Researchers at Icon Mount Sinai have made breakthrough discoveries in many fields vital to
0:23.0	advancing the health of patients, including cancer, COVID and long COVID, cardiology, neuroscience, and
0:30.4	artificial intelligence. The Icon School of Medicine at Mount Sinai, we find a way. Morgan State
0:37.3	University, a Baltimore, Maryland,
0:39.4	Carnegie R2 doctoral research institution, offers more than 100 academic programs and awards
0:45.4	degrees at the baccalaureate, master's, and doctoral levels, is furthering their mission of
0:50.4	growing the future leading the world. Morgan continues to address the needs and challenges of the modern urban environment.
0:57.4	With a four-year quadrupling of research, more than a dozen new doctoral programs,
1:02.4	and eight new national centers of excellence, Morgan is positioned to achieve Carnegie R1
1:07.8	designation in the next five years.
1:10.4	To learn more about Morgan and their ascension to R1, visit morgan.edu.
1:15.3	combe.
1:21.2	Welcome to the science podcast for July 10, 2020.
1:26.8	I'm Sarah Crespi.
1:28.2	First up this week, we have contributing correspondent Kai Kupershman.
1:32.5	He talks about the success of a fast-moving megat trial for coronavirus treatments.
1:38.6	Next, we have producer Megan Cantwell.
1:40.6	She talks with researcher Sao Obedahya about transferring the benefits of exercise by
1:46.6	transferring blood in mice. Now we have contributing correspondent Kai Kouffer Schmidt. He wrote
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Science Podcast, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Science Podcast and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.